Molecular Biomarkers in Glioma (Mechanisms and Therapeutic Implications of Hypermutation in Gliomas)

ANALYTE_TYPE - Analyte Type (phv00426776.v1.p1)
BODY_SITE - Body site where sample was collected (phv00426775.v1.p1)
CONSENT - Consent group as determined by DAC (phv00426765.v1.p1)
DIAGNOSIS - Subject diagnosis (phv00426773.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00426778.v1.p1)
IS_TUMOR - Tumor status (phv00426777.v1.p1)
PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00426779.v1.p1)
PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00426780.v1.p1)
SAMPLE_ID - Sample ID (phv00426774.v1.p1)
SAMPLE_ID - Sample ID (phv00426769.v1.p1)
SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00426767.v1.p1)
SUBJECT_ID - Subject ID (phv00426764.v1.p1)
SUBJECT_ID - Subject ID (phv00426770.v1.p1)
SUBJECT_ID - Subject ID (phv00426768.v1.p1)
SUBJECT_SOURCE - Source repository where subjects originate (phv00426766.v1.p1)
TUMOR_GRADE - Tumor grade of sample (phv00426781.v1.p1)